Skip to content

Surgery Partners, Inc. SGRY Income Loss From Equity Method Investments Net Of Dividends Or Distributions

Income Loss From Equity Method Investments Net Of Dividends Or Distributions at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.99B-49.1%

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s income loss from equity method investments net of dividends or distributions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s income loss from equity method investments net of dividends or distributions?
Surgery Partners, Inc. (SGRY) reported income loss from equity method investments net of dividends or distributions of -$2.6M in Q1 2026.
How has Surgery Partners, Inc.'s income loss from equity method investments net of dividends or distributions changed year-over-year?
Surgery Partners, Inc.'s income loss from equity method investments net of dividends or distributions decreased by 136.4% year-over-year, from -$1.1M to -$2.6M.
What is the long-term trend for Surgery Partners, Inc.'s income loss from equity method investments net of dividends or distributions?
Over 2 years (2021 to 2025), Surgery Partners, Inc.'s income loss from equity method investments net of dividends or distributions has grown at a 100.0% compound annual growth rate (CAGR), from -$200K to $800K.